UK 21:16 Friday, 20 November 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Logo
Menu

AVO

AVO

Advanced Oncotherapy – If You Owe The Bank A Quid…..

Tom Winnifrith often reminds us that if we owe the bank a quid, we are in trouble, but if we owe the bank a million quid it is the bank which is in trouble. In the case of AIM-disaster Advanced Oncotherapy (AVO), the debt is £10 million – which it cannot repay by the settlement date as it is running on vapours. 

AVO

Advanced Oncotherapy – share price death & directors grabbing the assets postponed by a few weeks

Advanced Oncotherapy (AVO) has raised another £1.37 million via the issuance of secured convertible loan notes. Great. £6.345 million of such CULS have now been issued but such is the profligacy of this abomination of an investment that this money will last for only a few more weeks. By the end of May the Fat Lady could well be singing. So who would benefit from that?

AVO

Advanced Oncotherapy and those dreaded words: Strategic Review

Over the the past decade Nigel Somerville and I have warned folks about this dog with fleas, almost as many times as I have had inappropriate thoughts about Cheryl Cole. With the shares in the minus 99% club, I guess we are already vindicated but today comes yet more bad news for Advanced Oncotherapy (AVO). As Old Mother Mike Walters, who is the sort of man who would have tipped this cash guzzling POS which has deceived its investors on a serial basis, would have said as he apologised for another duff share tip: “Oh dear, Oh dear” We start with the dreaded words “strategic review.”

AVO

Advanced Oncotherapy – New Record Low But How Bad Will It Get?

Paid for researcher Hardman may keep on telling mug punters that AIM-listed Advanced Oncotherapy (AVO) is a great company with a target price of gazillions, but the reality is that this cash-guzzling outfit which keeps on failing to deliver any income, is running out of funding options as the price crashes ever lower. Just how bad could it get?

AVO

Advanced Oncotherapy: It Is Surely In Real Trouble Now, the Fat Lady awaits

It seems that no amount of ramping can help AIM-listed Advanced Oncotherapy (AVO) now. The company is in deep shit – and has essentially admitted as much. I would suggest also that the recent note from pay-as-you-go “researcher” (to be polite) Hardman is also an almighty sell signal. At the root of the problem is the cash-guzzling nature of the business, but with a 25p par price and the shares now at just 7.5p it is clear that shareholders are about to take a bath. Or the whole shooting match could follow fellow proton therapy outfit Rutherford Health (RUTH - ex-of the Aquis lobster pot) to the great central bank in the sky. Anyone holding is, in my view, insane.

AVO

Advanced Oncotherapy – is the funding farce about to end, prompting a share price collapse? This company could well go bust!

Each month, Advanced Oncotherapy (AVO) needs between £1 million and £2 million to keep the lights on. And to date, each month Odey Asset Management has been writing a cheque, buying shares at 25p (par value) to keep the show on the road. But the shares are slipping and is this farce about to end prompting a share price collapse?

AVO

Advanced Oncotherapy – Worth 156p, Hardman? You’re ‘Avin’ A Giraffe

Paid-for investment "research" prostitute Hardman has released an update on AIM-listed Advanced Oncotherapy (AVO). This means that 1) the company is desperate for cash (no surprises there!), 2) a placing is on the way and 3) that Crispin Odey is sweating over his multiple purchases at a premium at 25p per share when the shares were trading below the 25p par price, given that they are now worth just 11.25p per share. I have much time for Odey, but he has surely called this one spectacularly wrong on multiple occasions.

AVO

Advanced Oncotherapy – Don’t Be Fooled By Today’s Pathetic Ramparoonie

We all know AIM-listed Advanced Oncotherapy (AVO) faces a funding crisis: it was sending around £2.6 million every month to the great central bank in the sky during the last reporting period, the interims to June 2022, when it had just £2.5 million of cash left over. Worse still, only a fool (step forward Crispin Odey?) would pay the par price of 25p for equity trading in the market now at just 12.25p. So without a capital reorganisation, the company is truly skewered.

AVO

Letter to the FCA – Odey Asset Management wasting clients cash?

I have commented extensively on this issue. I cannot understand how Odey is not both creating a false market in shares in Advanced Oncotherapy (AVO) – so inflating its AUM - but also knowingly and deliberately losing money for clients. I have written to the FCA asking it to examine the matter

Request that you investigate Odey Asset Management over share dealings in Advanced Oncotherapy

AVO

Advanced Oncotherapy – Scraping The Barrel - what is Crispin Odey doing with his client's cash?: SELL

AIM-listed Advanced Oncotherapy (AVO) has announced that it has raised another £1.5 million from an existing institutional investor at 25p per share, the par price below which the law prevents the issue of confetti. With the stock having closed last week at just 16.75p, this is surely pure madness on the part of that institutional investor – who we are reliably told is none other than Crispin Odey. How his compliance officer is allowing this, heaven only knows.

AVO

At what point does Daddy Pig’s compliance officer put a stop to the Advanced Oncotherapy farce?

I do not believe that Advanced Oncotherapy (AVO) will ever generate a cent of positive free cashflow as the demand for the proton therapy services it will offer at some point in 2023 is, in my view, already fully catered for with existing capacity. Others, notably a fund management firm run by a chap who looks remarkably like Daddy Pig, father of Peppa, disagree but what we might agree on its that, until late 2023, there is no doubt that Advanced will continue to guzzle cash. Which makes the next bailout placing only a matter of time.

AVO

Advanced Oncotherapy – Yet Another Fundraise As Odey Doubles Down Again

AIM-listed Advanced Oncotherapy (AVO) has announced yet another fundraise – this time for £6 million (before expenses) for the issue of another 24 million bits of confetti and associated warrants at 25p – the par price of the shares (below which it is not permitted to issue stock). The grateful recipient of the latest round of paper? Step forward clients of Odey Asset Management as Crispin Odey’s outfit doubles down yet again.

AVO

Advanced Oncotherapy – Has It Broken AIM Rule 11 and missed another deadline?

The end of August is generally regarded as the end of summer here in the UK, but the official date for the beginning of autumn is actually September 23 for this year. It is a moot point for most, but not so for AIM-listed Advanced Oncotherapy (AVO) – which had been promising that its first LIGHT medical proton bean unit would be up and running by the end of the summer.

AVO

Advanced Oncotherapy’s latest fund raise, this is just taking the piss

The real problem Advanced Oncotherapy (AVO) faces, as I explained here, is that there is not enough demand for its Harley Street proton centre to make a profit even when its LIGHT system is up and running. But for now, LIGHT is not up and running, the company is guzzling cash and that brings us to today’s latest keep the LIGHTs on fund raise. Advance really is taking the piss with its excuses.

previous 20 Page 2 of 15 (291 articles) next 20

Latest News

Show All

Recent Comments

TOM
TOM20 Nov 2026
naughty snake dodger, i love it
Tom Winnifrith Bearcast: a few thoughts on Skins and Opti
Sohail
Sohail20 Nov 2026
I Think Noel will be very unhappy today.Investors have to learn to take personal responsibility for their own investment decisions.I lost a fortune in Minoan but it was down to me.As for Kefi it will fly in bull market conditions.Its no surprise in a bear market for gold it will fall further than a producing mine in a safer jurisdiction.
Tom Winnifrith Bearcast: Noel emails me to say I am a f***ing c**t
Sohail
Sohail20 Nov 2026
Tom i think there is little interest in skins now.We await results and brokers forecasts.The plunge in the share price is unsurprising given the lack of visibility of earnings .
Tom Winnifrith Bearcast: a few thoughts on Skins and Opti
TOYIN
TOYIN20 Nov 2026
An ex employee will have zero up to date information on the running of the company, I can understand them saying it was a shit show when Walter was in charge, but that is irrelevant, every man and his dog knows it was a shit show back then. Non event.
Tom Winnifrith Bearcast: a few thoughts on Skins and Opti
KEVINRTAYLOR
KEVINRTAYLOR20 Nov 2026
I was at Mello but didn't attend this presentation, although I was told about it.Lukas Mikelionis describes himself as an investigative journalist: https://www.mikelionis.com/He has been working on this story for a long time and tried to take over the Kooth presentation with loads of questions, which they tried to answer at first but then decided that he'd asked enough questions and needed to give way for the other investors to put their own questions forward. I was told that Kooth had claimed that the case had already been dealt with. Evil Banksta
A Frosty Exchange at Mello rampfest - Kooth and the bear dossier
DUCKnDIVE
DUCKnDIVE20 Nov 2026
Tsk, tsk…O'Hara's Skins shareholding is already below 3% so he has been free for months to do as he pleases with those shares, without notifying anyone. Of course, he's not going to want to tell his shareholders that he is desperate enough to sell Skins shares at 4p as they would run a mile. Other major Skins shareholders would risk crossing a notifiable threshold of course if they were selling but no TR1s in view yet.And you really should elaborate on "shit show", you naughty snake dodger. Is this new intel that you have somehow resisted the urge to divulge? Or was it SH moaning about the way he was resigned?
Tom Winnifrith Bearcast: a few thoughts on Skins and Opti
JASKK
JASKK20 Nov 2026
I personally wouldn’t buy until the gold price has consolidated. I hold no gold stocks apart from what’s in Ruffer. I’m yet to be convinced that Golds parabolic rise last year wasn’t a bubble. If the market does crash I don’t believe there will be QE this time and governments will be forced into living within their means which will be painful. The big banks are now structurally sound and that all central banks care about. Cash (at the moment ) is king.
Tom Winnifrith Bearcast: Noel emails me to say I am a f***ing c**t
DAVID FRASER
DAVID FRASER20 Nov 2026
That doesn’t really answer my question…..
Tom Winnifrith Bearcast: Noel emails me to say I am a f***ing c**t
AIMINVESTOR
AIMINVESTOR19 Nov 2026
Lukas Mikelionis is an investigative journalist!Maybe someone to talk to?This story looks awful
A Frosty Exchange at Mello rampfest - Kooth and the bear dossier

Complete Coverage

That Was the Week that Was 7 Days of ShareProphets

Friday »

Bear
New Sharestock speaker announced: the Dark Destroyer is back! Book Now!
  • By Tom Winnifrith
  • 5 hours ago
ENET
Ethernity Networks – $1.36m patent licensing agreement, but still financial uncertainty?…
  • By Steve Moore
  • 5 hours ago
Bearcast
Tom Winnifrith Bearcast No 2: Reabold suspended, everything that is wrong about AIM
  • By Tom Winnifrith
  • 6 hours ago
PR1
Pri0r1ty Intelligence Group: more confetti vicar?
  • By Tom Winnifrith
  • 6 hours ago
GoldfishShark
Video: ‘Massive Distortion’, Gold’s Bottom & Why The ‘Largest Upside’ is in Silver Miners
  • By Tom Winnifrith
  • 7 hours ago
FADL
Fadel Partners – states “pleased to announce” recommended offer, but it’s ANOTHER AIM IPO Roll-Call of Shame…
  • By Steve Moore
  • 7 hours ago
Bearcast
Tom Winnifrith Bearcast: a few thoughts on Skins and Opti
  • By Tom Winnifrith
  • 8 hours ago
ECP
EXPOSE: Eight Capital Partners the rebuttal is more ludicrous than the original RNS
  • By Tom Winnifrith
  • 9 hours ago
CML
CML Microsystems – interims, winning share tip value?
  • By HotStockRockets
  • 10 hours ago
THRU
Thruvision – an upcoming “potential requirement” for additional funding or an actual requirement?…
  • By Steve Moore
  • 10 hours ago

Thursday »

BTC
London Bitcoin’s dismal interim results & rapacious management greed
  • By Tom Winnifrith
  • 1 day ago
KOO
A Frosty Exchange at Mello rampfest - Kooth and the bear dossier
  • By Tom Winnifrith
  • 1 day ago
IKA
Ilika – argues “continued progress in the commercialisation”, but how materially?…
  • By Steve Moore
  • 1 day ago
RST
Restore plc – an “expects… to be at least in line with consensus expectations” Buy
  • By Tom Winnifrith & Steve Moore
  • 1 day ago
MCB
McBride – states “resilient and growing underlying demand”, But…
  • By Steve Moore
  • 1 day ago
QQ
QinetiQ – interims, a growth and shareholder returns Buy
  • By Tom Winnifrith & Steve Moore
  • 1 day ago
BMV
Bluebird Mining Ventures - the "share buy back" spoofs not working
  • By Tom Winnifrith
  • 1 day ago
Bearcast
Tom Winnifrith Bearcast: Noel emails me to say I am a f***ing c**t
  • By Tom Winnifrith
  • 1 day ago
CTA
CT Automotive – profit warning and how much confidence to really have in its argued 2027 recovery?
  • By Steve Moore
  • 1 day ago

Wednesday »

Bear
Blue Moon Metals: From Russia, With Love, a new bear dossier from Fraser Perring
  • By Tom Winnifrith
  • 2 days ago
MSLH
Marshalls – how “resilient” is its trading and outlook?…
  • By Steve Moore
  • 2 days ago
Collapsing-Reactor
Bad News travels slowly, another red flag as Nuburu warns of delayed financials for Q3 2026
  • By Tom Winnifrith
  • 2 days ago
HAS
Hays plc – emphasises profit “materially above current consensus”, but what’s already in the price?
  • By Steve Moore
  • 2 days ago
Bearcast
Tom Winnifrith Bearcast: I hate being lied to so much & as gold falls I ask why I keep owning Golden Prospect
  • By Tom Winnifrith
  • 2 days ago
MPAL
Dirty Dozen: the 12 most-read stories about Medpal AI
  • By Tom Winnifrith
  • 2 days ago
MPAC
Mpac – argues “encouraging” pipeline of potential opportunities, but what about pipeline conversion?…
  • By Steve Moore
  • 2 days ago
GPM
Will I be taking up my bonus Golden Prospect shares asks the Dinosaur?
  • By Tom Winnifrith
  • 3 days ago
GEX
Dirty Dozen: the 12 most-read stories about Georgina Energy
  • By Tom Winnifrith
  • 3 days ago
Bear
AI crash Update, post Nvidia sex scandal, 3 clear zeros to short 
  • By Lucian Miers
  • 3 days ago
Boom
Oak Securities – rumours of FCA enquiry doing the rounds
  • By Tom Winnifrith
  • 3 days ago

Tuesday »

PULS
Pulsar Group – after a “Capital Access Window… to make it easier to reach a broader range of investors”…
  • By Steve Moore
  • 3 days ago
Bearcast
Tom Winnifrith Bearcast: My supposed grievances
  • By Tom Winnifrith
  • 3 days ago
PANR
Pantheon Resources placing – a success or a failure?
  • By Tom Winnifrith
  • 3 days ago
TRI
Trifast – after last month “confident in delivering further margin improvement in H2”, what about now with its half-year results?
  • By Steve Moore
  • 3 days ago
AMRQ
Amaroq at 102p: could be 220p, 530p or 1000p says Citi
  • By Tom Winnifrith
  • 3 days ago
G4M
Gear4Music heading into reverse gear: do not catch the falling knife
  • By Tom Winnifrith
  • 3 days ago
FLO
Flowtech Fluidpower – after “confident in its outlook for the remainder of the year” in September, what about now a “Trading Update”?…
  • By Steve Moore
  • 3 days ago
EU_flag
Shocking new jobs data, Britain cannot keep going like this and the answer is not to send £750m a week to the EU
  • By Tom Winnifrith
  • 3 days ago
TERN
Tern: is it game over?
  • By Tom Winnifrith
  • 3 days ago
OPTI
Lyin’ Steve O’Hara getting really desperate in a second utterly misleading video
  • By Tom Winnifrith
  • 3 days ago

Monday »

QED
Quadrise – “pleased to announce… Valkor funds receipt”, but how significant?
  • By Steve Moore
  • 4 days ago
HAMA
The price of retaining a talent like Nicola Horlick
  • By Tom Winnifrith
  • 4 days ago
MEGP
ME Group International – ‘year-end trading update’ emphasises “continued growth in laundry operations”, but what about overall?…
  • By Steve Moore
  • 4 days ago
Bearcast
Tom Winnifrith Bearcast: Police Time wastin' Steve O'Hara and his shares, just so disingeneous
  • By Tom Winnifrith
  • 4 days ago
MPAL
Medpal AI – has Clear Capital been selling shares?
  • By Tom Winnifrith
  • 4 days ago
SWC
My NBF seems to have lost £93.5 million on bitcoin
  • By Tom Winnifrith
  • 4 days ago
SOLI
Solid State – “pleased” with first half performance, but what about the bottom-line outlook?
  • By Steve Moore
  • 4 days ago
GEX
Weather in Wiluna & Wrexham – a deep dive that the FCA should be all over
  • By Tom Winnifrith
  • 4 days ago
AMRQ
Canaccord upgrades stance and increases Amaroq target price
  • By Tom Winnifrith
  • 4 days ago
GEX
EXPOSE: Georgina Energy: more lies check out actual road closures in WA & do some geekish meteorology!
  • By Tom Winnifrith
  • 4 days ago

Sunday »

ECP
Letter to FRC: Marking your card on Eight Capital & Bright Graham Murray
  • By Tom Winnifrith
  • 5 days ago
ALU
A “positive trading momentum” recovery Buy
  • By HotStockRockets
  • 5 days ago
Bearcast
Tom Winnifrith bearcast: when does Pantheon run out of cash and why the blue wave in the US will sink it
  • By Tom Winnifrith
  • 5 days ago
Gold
The View From The Montana Log-Cabin As Gold Falls Again: Time To Do Precisely Nothing!
  • By Nigel Somerville
  • 6 days ago
Quiz
The ShareProphets Sunday Pub Quiz #372
  • By Darren Atwater
  • 6 days ago
Blackboard
Visual Aid: The World’s Longest Place Names, unlike yesterday New Zealand beats Wales into second
  • By Darren Atwater
  • 6 days ago
Reading
Sunday Long Reads: Worst Service Station, Russell Brand, Conscious AI, Bougie Bakeries, the Patron Saint Of Strippers & Stocks
  • By Darren Atwater
  • 6 days ago
Top-10
Notes from Underground – Most read articles for the week ending November 14
  • By Darren Atwater
  • 6 days ago

Saturday »

Bearcast
Tom Winnifrith Bearcast: how low can bitcoin plunge and how to play it with shares trades
  • By Tom Winnifrith
  • 6 days ago
THS
Tharisa – another listing for its shares, an improving liquidity Buy
  • By HotStockRockets
  • 6 days ago
AMRQ
Amaroq – Q3 “operations continuing to ramp up according to plan”, Buy
  • By Tom Winnifrith & Steve Moore
  • 6 days ago
Roulette
'The Takeover 12' Great British Takeover stakes competition leading picks performance update – again some improvement...
  • By Steve Moore
  • 7 days ago

Friday »

W7L
Warpaint London – “Change of Adviser”, how’s the ‘significantly more second half weighted’ going?
  • By Steve Moore
  • 7 days ago
Bearcast
Tom Winnifrith Bearcast: Henry Gewanter does pick 'em, why bears matter and Andrew Bell & Jensen Huang, the common link
  • By Tom Winnifrith
  • 7 days ago
RBN
Robinson plc – after previously another profit warning, now announces a “Directorate change”…
  • By Steve Moore
  • 7 days ago
AMRQ
Panmure Liberum on Amaroq – I just do not get its maths
  • By Tom Winnifrith
  • 7 days ago
Boom
Davion Healthcare PLC a $306m Nasdaq IPO on October 22, 90% down already – have we exported a complete turd ( or worse) to the USA?
  • By Tom Winnifrith
  • 7 days ago
DFS
DFS Furniture – “full-year profit expectations… carry a wider range of potential outcomes”, but how likely really now is a good outcome?
  • By Steve Moore
  • 7 days ago
Bear
Video: Why This Is ‘Much Worse’ Than The 1970s – And That’s Good For Gold
  • By Tom Winnifrith
  • 7 days ago
MPAL
Medpal AI and the death jabs – I know it’s in the Daily Mail but it might be right!
  • By Tom Winnifrith
  • 7 days ago
AMRQ
Amaroq: a few thoughts on the idea of a dividend
  • By Tom Winnifrith
  • 8 days ago
Bitcoin
Bitcoin holders: tell me why Peter Schiff is wrong as my 96 year old father in law outperforms Dominic Frisby by 23%
  • By Tom Winnifrith
  • 8 days ago